Inclisiran can be given in primary care settings as a twice-yearly injection to people with high cholesterol who have already had a previous cardiovascular event to reduce the chances of them having another. It can be used on its own or alongside statins or other cholesterol lowering drugs.
Inclisiran works in a new way. It is the first of a new type of cholesterol-lowering treatment which uses RNA interference (RNAi) to boost the liver’s ability to remove harmful cholesterol from the blood.
We ran a Group Consultation to introduce this new injection and were able to provide it to patients at the same time. We have had very positive feedback from our patients and it was a huge success.
Please see below a few pictures and some feedback from our patients